16-89919722-T-C
Position:
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_002386.4(MC1R):c.464T>C(p.Ile155Thr) variant causes a missense change. The variant allele was found at a frequency of 0.0094 in 1,606,272 control chromosomes in the GnomAD database, including 102 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Genomes: 𝑓 0.0066 ( 3 hom., cov: 33)
Exomes 𝑓: 0.0097 ( 99 hom. )
Consequence
MC1R
NM_002386.4 missense
NM_002386.4 missense
Scores
5
4
8
Clinical Significance
Conservation
PhyloP100: 5.05
Genes affected
MC1R (HGNC:6929): (melanocortin 1 receptor) This intronless gene encodes the receptor protein for melanocyte-stimulating hormone (MSH). The encoded protein, a seven pass transmembrane G protein coupled receptor, controls melanogenesis. Two types of melanin exist: red pheomelanin and black eumelanin. Gene mutations that lead to a loss in function are associated with increased pheomelanin production, which leads to lighter skin and hair color. Eumelanin is photoprotective but pheomelanin may contribute to UV-induced skin damage by generating free radicals upon UV radiation. Binding of MSH to its receptor activates the receptor and stimulates eumelanin synthesis. This receptor is a major determining factor in sun sensitivity and is a genetic risk factor for melanoma and non-melanoma skin cancer. Over 30 variant alleles have been identified which correlate with skin and hair color, providing evidence that this gene is an important component in determining normal human pigment variation. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -8 ACMG points.
BP4
Computational evidence support a benign effect (MetaRNN=0.0065425932).
BS2
High AC in GnomAd4 at 1008 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
MC1R | NM_002386.4 | c.464T>C | p.Ile155Thr | missense_variant | 1/1 | ENST00000555147.2 | NP_002377.4 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MC1R | ENST00000555147.2 | c.464T>C | p.Ile155Thr | missense_variant | 1/1 | NM_002386.4 | ENSP00000451605 | P1 | ||
MC1R | ENST00000555427.1 | c.464T>C | p.Ile155Thr | missense_variant | 3/4 | 5 | ENSP00000451760 | |||
MC1R | ENST00000639847.1 | c.464T>C | p.Ile155Thr | missense_variant | 3/3 | 5 | ENSP00000492011 | P1 |
Frequencies
GnomAD3 genomes AF: 0.00661 AC: 1007AN: 152244Hom.: 3 Cov.: 33
GnomAD3 genomes
AF:
AC:
1007
AN:
152244
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00564 AC: 1366AN: 242204Hom.: 1 AF XY: 0.00564 AC XY: 745AN XY: 132048
GnomAD3 exomes
AF:
AC:
1366
AN:
242204
Hom.:
AF XY:
AC XY:
745
AN XY:
132048
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00969 AC: 14089AN: 1453910Hom.: 99 Cov.: 34 AF XY: 0.00935 AC XY: 6764AN XY: 723646
GnomAD4 exome
AF:
AC:
14089
AN:
1453910
Hom.:
Cov.:
34
AF XY:
AC XY:
6764
AN XY:
723646
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00662 AC: 1008AN: 152362Hom.: 3 Cov.: 33 AF XY: 0.00553 AC XY: 412AN XY: 74504
GnomAD4 genome
AF:
AC:
1008
AN:
152362
Hom.:
Cov.:
33
AF XY:
AC XY:
412
AN XY:
74504
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
TwinsUK
AF:
AC:
35
ALSPAC
AF:
AC:
31
ESP6500AA
AF:
AC:
13
ESP6500EA
AF:
AC:
90
ExAC
AF:
AC:
635
Asia WGS
AF:
AC:
3
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Conflicting classifications of pathogenicity
Submissions summary: Pathogenic:1Uncertain:2Benign:4
Revision: criteria provided, conflicting classifications
LINK: link
Submissions by phenotype
not provided Pathogenic:1Uncertain:2Benign:1
Benign, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | May 01, 2024 | MC1R: BP4, BS1, BS2 - |
Uncertain significance, no assertion criteria provided | clinical testing | Department of Pathology and Laboratory Medicine, Sinai Health System | - | The MC1R p.Ile155Thr variant was reported in the literature with an association to red hair colour, fair skin colour, and melanoma risk phenotypes (Morgan_2018_PMID:30531825; Liu_2015_PMID:25963972; Williams_2011_PMID:21128237; Raimondi_2008_PMID:18366057). The variant was identified in dbSNP (ID: rs1110400), ClinVar (classified as benign 1x, likely benign 2x, pathogenic 1x by GeneDx, and uncertain significance 1x), and LOVD 3.0, however it was not identified in Cosmic. The variant was identified in control databases in 1566 of 273582 chromosomes (1 homozygous) at a frequency of 0.005724 increasing the likelihood this could be a low frequency benign variant (Genome Aggregation Database Feb 27, 2017). The variant was observed in the following populations: European (non-Finnish) in 1180 of 126992 chromosomes (freq: 0.009292), Ashkenazi Jewish in 88 of 10294 chromosomes (freq: 0.008549), Other in 45 of 7096 chromosomes (freq: 0.006342), Latino in 148 of 35326 chromosomes (freq: 0.00419), African in 55 of 24388 chromosomes (freq: 0.002255), European (Finnish) in 36 of 19442 chromosomes (freq: 0.001852) and South Asian in 14 of 30564 chromosomes (freq: 0.000458); it was not observed in the East Asian population. One functional study showed I155T G-protein coupled receptors, which are expressed on melanocytes and play a role in pigmentation regulation, displayed an 85% decrease in plasma membrane receptor levels (Beaumont_2005_PMID:15972726). Although the p.Ile155 residue is not conserved in mammals and other organisms, computational analyses (PolyPhen-2, SIFT, BLOSUM, MutationTaster) suggest that the variant may impact the protein. The variant occurs outside of the splicing consensus sequence and in silico or computational prediction software programs (SpliceSiteFinder, MaxEntScan, NNSPLICE, GeneSplicer) do not predict a difference in splicing. In summary, based on the above information the clinical significance of this variant cannot be determined with certainty at this time. This variant is classified as a variant of uncertain significance. - |
Uncertain significance, criteria provided, single submitter | clinical testing | ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories | Oct 23, 2023 | The MC1R c.464T>C; p.Ile155Thr variant (rs1110400) is reported in the literature in individuals affected with melanoma (Aviles 2012, Bassoli 2013, Hatvani 2014, Puig-Butille 2013). However, several studies found only a slightly increased association with melanoma, with odds ratios of 1.14-2.45 (Morgan 2018, Raimondi 2008, Williams 2011). This variant is also reported in ClinVar (Variation ID: 239154), and is found in the general population with an overall allele frequency of 0.57% (1566/273582 alleles, including a single homozygote) in the Genome Aggregation Database. The isoleucine at codon 155 is highly conserved, and computational analyses are uncertain whether this variant is neutral or deleterious (REVEL: 0.234). In vitro functional analyses demonstrate decreased cell surface expression of the MC1R protein and reduced cAMP signaling (Beaumont 2007). Based on available information, it is uncertain whether this variant increases the risk for melanoma. References: Aviles JA et al. Phenotypic and histologic characteristics of cutaneous melanoma in patients with melanocortin-1 receptor polymorphisms. Actas Dermosifiliogr. 2012 Jan;103(1):44-50. PMID: 22464597. Bassoli S et al. CDKN2A and MC1R variants influence dermoscopic and confocal features of benign melanocytic lesions in multiple melanoma patients. Exp Dermatol. 2013 Jun;22(6):411-6. PMID: 23711066. Beaumont KA et al. Receptor function, dominant negative activity and phenotype correlations for MC1R variant alleles. Hum Mol Genet. 2007 Sep 15;16(18):2249-60. PMID: 17616515. Hatvani Z et al. Genotype analysis in Hungarian patients with multiple primary melanoma. Exp Dermatol. 2014 May;23(5):361-4. PMID: 24660985. Morgan MD et al. Genome-wide study of hair colour in UK Biobank explains most of the SNP heritability. Nat Commun. 2018 Dec 10;9(1):5271. PMID: 30531825. Puig-Butille JA et al. Distribution of MC1R variants among melanoma subtypes: p.R163Q is associated with lentigo maligna melanoma in a Mediterranean population. Br J Dermatol. 2013 Oct;169(4):804-11. PMID: 23647022. Raimondi S et al. MC1R variants, melanoma and red hair color phenotype: a meta-analysis. Int J Cancer. 2008 Jun 15;122(12):2753-60. PMID: 18366057. Williams PF et al. Melanocortin 1 receptor and risk of cutaneous melanoma: a meta-analysis and estimates of population burden. Int J Cancer. 2011 Oct 1;129(7):1730-40. PMID: 21128237. - |
Pathogenic, criteria provided, single submitter | clinical testing | GeneDx | Jul 01, 2016 | The I155T variant in the MC1R gene has been reported numerous times in the both the heterozygous and homozygous states in association with MC1R-related phenotypes including red hair, changes in skin pigmentation, and an increased risk for UV exposure-related melanoma (Flanagan et al., 2000; Beaumont et al., 2007; Raimondi et al., 2008; Cust et al., 2012; Puig-Butillé et al., 2013). The NHLBI Exome Sequencing Project reports I155T was observed in 1.05% (90/8598) alleles from individuals of European American ancestry. The I155T variant is a non-conservative amino acid substitution, which is likely to impact secondary protein structure as these residues differ in polarity, charge, size and/or other properties. This substitution occurs at a position where amino acids with similar properties to Isoleucine are tolerated across species. Functional studies demonstrate that I155T reduces cell surface expression of the MC1R protein and results in loss of cAMP signaling (Beaumont et al., 2007). - |
Melanoma, cutaneous malignant, susceptibility to, 5 Benign:2
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Feb 01, 2024 | - - |
Likely benign, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Apr 27, 2017 | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). Publications were found based on this search. The evidence from the literature, in combination with allele frequency data from public databases where available, was sufficient to determine this variant is unlikely to cause disease. Therefore, this variant is classified as likely benign. - |
not specified Benign:1
Likely benign, criteria provided, single submitter | clinical testing | PreventionGenetics, part of Exact Sciences | - | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Benign
DANN
Uncertain
DEOGEN2
Uncertain
.;T;T;.
Eigen
Uncertain
Eigen_PC
Uncertain
FATHMM_MKL
Pathogenic
D
LIST_S2
Benign
T;.;T;T
MetaRNN
Benign
T;T;T;T
MetaSVM
Benign
T
MutationAssessor
Pathogenic
.;M;M;.
MutationTaster
Benign
D;D
PROVEAN
Pathogenic
D;.;D;N
REVEL
Benign
Sift
Pathogenic
D;.;D;D
Sift4G
Pathogenic
D;.;D;D
Polyphen
0.99
.;D;D;.
Vest4
MVP
MPC
0.10
ClinPred
T
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at